Thomas Eiermann

2.8k total citations
65 papers, 2.0k citations indexed

About

Thomas Eiermann is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Thomas Eiermann has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 12 papers in Genetics and 10 papers in Hematology. Recurrent topics in Thomas Eiermann's work include T-cell and B-cell Immunology (35 papers), Immune Cell Function and Interaction (28 papers) and Diabetes and associated disorders (12 papers). Thomas Eiermann is often cited by papers focused on T-cell and B-cell Immunology (35 papers), Immune Cell Function and Interaction (28 papers) and Diabetes and associated disorders (12 papers). Thomas Eiermann collaborates with scholars based in Germany, United States and Switzerland. Thomas Eiermann's co-authors include Marcus Schmitt‐Egenolf, Wolfram Sterry, Wolf‐­Henning Boehncke, Sonja Schrepfer, Markward Ständer, Hans‐Dieter Volk, Hermann Reichenspurner, Robert C. Robbins, T. Deuse and Axel R. Zander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Eiermann

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Eiermann Germany 25 1.0k 434 362 361 359 65 2.0k
André Gothot Belgium 22 469 0.5× 360 0.8× 559 1.5× 696 1.9× 316 0.9× 69 1.9k
Viktor Roschke United States 16 2.2k 2.1× 249 0.6× 497 1.4× 211 0.6× 86 0.2× 18 3.2k
Nicolas Degauque France 31 2.1k 2.1× 415 1.0× 369 1.0× 172 0.5× 645 1.8× 87 3.3k
Mario Arpinati Italy 22 1.2k 1.2× 308 0.7× 445 1.2× 882 2.4× 426 1.2× 68 2.7k
Tai‐Gyu Kim South Korea 27 1.4k 1.4× 639 1.5× 617 1.7× 243 0.7× 106 0.3× 170 2.3k
Marc L. Turner United Kingdom 24 571 0.6× 212 0.5× 537 1.5× 410 1.1× 156 0.4× 54 1.6k
Christophe Borg France 22 1.3k 1.2× 652 1.5× 500 1.4× 109 0.3× 370 1.0× 48 2.3k
Roberta Angeli Italy 16 1.7k 1.7× 527 1.2× 597 1.6× 246 0.7× 643 1.8× 19 3.5k
Carlijn Voermans Netherlands 32 845 0.8× 566 1.3× 985 2.7× 780 2.2× 325 0.9× 73 2.7k
HE Broxmeyer United States 17 611 0.6× 472 1.1× 494 1.4× 707 2.0× 244 0.7× 27 1.9k

Countries citing papers authored by Thomas Eiermann

Since Specialization
Citations

This map shows the geographic impact of Thomas Eiermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Eiermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Eiermann more than expected).

Fields of papers citing papers by Thomas Eiermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Eiermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Eiermann. The network helps show where Thomas Eiermann may publish in the future.

Co-authorship network of co-authors of Thomas Eiermann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Eiermann. A scholar is included among the top collaborators of Thomas Eiermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Eiermann. Thomas Eiermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinꝉ, Roland, Mireia Sospedra, Thomas Eiermann, & Tomas Olsson. (2021). Multiple sclerosis: doubling down on MHC. Trends in Genetics. 37(9). 784–797. 42 indexed citations
2.
Mascaretti, L, Carlo Carcassi, Thomas Eiermann, et al.. (2013). ACTIVITY OF EFI ACCREDITED LABORATORIES IN 2011: A PRELIMINARY ANALYSIS. Tissue Antigens. 81(5). 388–388. 1 indexed citations
3.
Stubbendorff, Mandy, T. Deuse, Xiaoqin Hua, et al.. (2013). Immunological Properties of Extraembryonic Human Mesenchymal Stromal Cells Derived from Gestational Tissue. Stem Cells and Development. 22(19). 2619–2629. 67 indexed citations
4.
Sputtek, Andreas, et al.. (2011). Assessment of physiologic natural killer cell cytotoxicity in vitro. Human Immunology. 72(11). 1007–1012. 11 indexed citations
5.
Kröger, Nicolaus, Tatjana Zabelina, Thomas Binder, et al.. (2009). HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen. Biology of Blood and Marrow Transplantation. 15(4). 454–462. 29 indexed citations
6.
Kelsch, Reinhard, Thomas M. C. Binder, H.‐A. Elsner, Thomas Eiermann, & Walter Sibrowski. (2009). An HLA‐DR11/DQ3 haplotype with a DRB1*0301 sequence motif in the third hypervariable region of the HLA‐DR beta‐1 chain: molecular and serological analysis of its generation in a European Caucasian family. Tissue Antigens. 74(4). 330–335. 1 indexed citations
7.
Atanackovic, Djordje, Tim Luetkens, Jens Panse, et al.. (2008). CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Haematologica. 93(3). 423–430. 53 indexed citations
8.
9.
Kröger, Nicolaus, Bronwen E. Shaw, Simona Iacobelli, et al.. (2005). Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. British Journal of Haematology. 129(5). 631–643. 82 indexed citations
10.
Rosinger, Silke, et al.. (2004). Preproinsulin‐Specific CD8+ T Cells Secrete IFNγ in Human Type 1 Diabetes. Annals of the New York Academy of Sciences. 1037(1). 22–25. 12 indexed citations
11.
Durinovic‐Belló, Ivana, Michael Schlosser, Hubert Kalbacher, et al.. (2003). Relationship between T and B Cell Responses to Proinsulin in Human Type 1 Diabetes. Annals of the New York Academy of Sciences. 1005(1). 288–294. 5 indexed citations
12.
Eiermann, Thomas, et al.. (2001). Jurkat Cell-Reactive Anti-Thymocyte Globulin Assessed Ex Vivo by Flow Cytometry Persists Three Weeks in Circulation. Journal of Hematotherapy & Stem Cell Research. 10(3). 385–390. 12 indexed citations
13.
Vejbaesya, Sasijit, et al.. (1998). Serological and molecular analysis of HLA class I and II alleles in Thai patients with psoriasis vulgaris. Tissue Antigens. 52(4). 389–392. 26 indexed citations
14.
Eiermann, Thomas, Florence Bettens, Pierre Tiberghien, et al.. (1998). HLA and alveolar echinococcosis. Tissue Antigens. 52(2). 124–129. 48 indexed citations
15.
16.
Schmitt‐Egenolf, Marcus, Thomas Eiermann, Wolf‐­Henning Boehncke, Markward Ständer, & Wolfram Sterry. (1996). Familial Juvenile Onset Psoriasis Is Associated with the Human Leukocyte Antigen (HLA) Class I side of the Extended Haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: A Population- And Family-Based Study. Journal of Investigative Dermatology. 106(4). 711–714. 93 indexed citations
17.
Gläser, Regine, Thomas Eiermann, Lutz Fricke, Holger Kirchner, & Gregor Bein. (1993). HLA DNA Preorgan Retrieval Donor Typing in Renal Transplantation. Vox Sanguinis. 65(4). 300–302. 4 indexed citations
18.
Schmitt‐Egenolf, Marcus, Wolf‐­Henning Boehncke, Markward Ständer, Thomas Eiermann, & Wolfram Sterry. (1993). Oligonucleotide Typing Reveals Association of Type I Psoriasis with the HLA-DRB1*0701/2, -DQA* 0201, -DQB1*0303 Extended Haplotype. Journal of Investigative Dermatology. 100(6). 749–752. 68 indexed citations
19.
Müller, Carlheinz & Thomas Eiermann. (1991). How many probes are needed for HLA-DPB1 typing with sequence-specific oligonucleotide probes? A theoretical approach using computer simulation. Human Immunology. 30(1). 22–26. 9 indexed citations
20.
Richter, Wiltrud, Thomas Eiermann, & Werner A. Scherbaum. (1990). Effect of Cytokines on Proliferation of Epstein Barr Virus-Transformed B Lymphocytes. Hybridoma. 9(1). 1–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Gothot Breakdown of academic impact, for papers by Viktor Roschke Breakdown of academic impact, for papers by Nicolas Degauque Breakdown of academic impact, for papers by Mario Arpinati Breakdown of academic impact, for papers by Tai‐Gyu Kim Breakdown of academic impact, for papers by Marc L. Turner Breakdown of academic impact, for papers by Christophe Borg Breakdown of academic impact, for papers by Roberta Angeli Breakdown of academic impact, for papers by Carlijn Voermans Breakdown of academic impact, for papers by HE Broxmeyer
Rankless by CCL
2026